Skip to main content

Rapid Expert Consultation on Allocating COVID-19 Monoclonal Antibody Therapies and Other Novel Therapeutics (January 29, 2021)

View Cover

Overview

Contributors

Description

This rapid expert consultation focuses on monoclonal antibody (mAbs) therapies authorized for use in patients infected with SARS-CoV-2. This consultation describes the approaches taken in different jurisdictions at the federal, state, and local/institutional levels to ensure an effective, equitable, and fair allocation of mAbs and points to challenges in reaching underserved patients.

The National Academies of Sciences, Engineering, and Medicine convened a standing committee of experts to help inform the Office of Science and Technology Policy on critical science and policy issues related to emerging infectious diseases and other public health threats. The standing committee includes members with expertise in emerging infectious diseases, public health, public health preparedness and response, biological sciences, clinical care and crisis standards of care, risk communication, and regulatory issues.

Topics

Suggested Citation

National Academies of Sciences, Engineering, and Medicine. 2021. Rapid Expert Consultation on Allocating COVID-19 Monoclonal Antibody Therapies and Other Novel Therapeutics (January 29, 2021). Washington, DC: The National Academies Press. https://doi.org/10.17226/26063.

Import this citation to:

Publication Info

34 pages | 8.5 x 11
DOI: https://doi.org/10.17226/26063
Contents
Rights

Copyright Information

The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:

  • Republish or display in another publication, presentation, or other media
  • Use in print or electronic course materials and dissertations
  • Share electronically via secure intranet or extranet
  • And more

For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.

Click here to obtain permission for Rapid Expert Consultation on Allocating COVID-19 Monoclonal Antibody Therapies and Other Novel Therapeutics (January 29, 2021).

Translation and Other Rights

For information on how to request permission to translate our work and for any other rights related query please click here.

Copyright.com Customer Service

For questions about using the Copyright.com service, please contact:

Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
E-mail: info@copyright.com
Web: https://www.copyright.com
Stats

Loading stats for Rapid Expert Consultation on Allocating COVID-19 Monoclonal Antibody Therapies and Other Novel Therapeutics (January 29, 2021)...